Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: A cluster randomized controlled trial

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 10, 2007, Pages 3591-3598

  Ellis, Michael W ^a   Griffith, Matthew E ^a   Dooley, David P ^a,d   McLean, Joseph C ^a   Jorgensen, James H ^b   Patterson, Jan E ^b,c   Davis, Kepler A ^a,e   Hawley, Joshua S ^a   Regules, Jason A ^a   Rivard, Robert G ^a   Gray, Paula J ^a   Ceremuga, Julia M ^a   DeJoseph, Mary A ^a   Hospenthal, Duane R ^a  

^a BROOKE ARMY MEDICAL CENTER   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^e EISENHOWER ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; METICILLIN; PLACEBO; PSEUDOMONIC ACID;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CLINICAL TRIAL; COMMUNITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; INFECTION PREVENTION; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOLDIER; STAPHYLOCOCCUS INFECTION;

ADMINISTRATION, INTRANASAL; ADULT; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; CULTURE MEDIA; DOUBLE-BLIND METHOD; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; MALE; METHICILLIN RESISTANCE; MILITARY PERSONNEL; MUPIROCIN; SPECIMEN HANDLING; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 34948867213     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01086-06     Document Type: Article

References (54)

1. Baggett, H. C., T. W. Hennessy, K. Rudolph, D. Bruden, A. Reasonover, A. Parkinson, R. Sparks, R. M. Donlan, P. Martinez, K. Mongkolrattanothai, and J. C. Butler. 2004. Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton-Valentine leukocidin during a furunculosis outbreak in rural Alaska, 1996-1998. J. Infect. Dis. 189:1565-1573.
2. Bannerman, T. L., G. A. Hancock, F. C. Tenover, and J. M. Miller. 1995. Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus. J. Clin. Microbiol. 33:551-555.
3. Buckingham, S. C., L. K. McDougal, L. D. Cathey, K. Comeaux, A. S. Craig, S. K. Fridkin, and F. C. Tenover. 2004. Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee children's hospital. Pediatr. Infect. Dis. J. 23:619-624.
4. Centers for Disease Control and Prevention. 1999. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus-Min nesota and North Dakota, 1997-1999. Morb. Mortal. Wkly. Rep. 48:707-710.
5. Centers for Disease Control and Prevention. 2003. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants-Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. Morb. Mortal. Wkly. Rep. 52:793-795.
6. Centers for Disease Control and Prevention. 2003. Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections-Los Angeles County, California, 2002-2003. Morb. Mortal. Wkly. Rep. 52:88.
7. Chambers, H. F. 2004. Mupirocin prophylaxis misses by a nose. Ann. Intern. Med. 140:484-485.
8. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing. Supplement M100-S15. Clinical and Laboratory Standards Institute, Wayne, PA.
9. Cookson, B. D. 1998. The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. J. Antimicrob. Chemother. 41:11-18.
10. Creech, C. B., T. R. Talbot, and W. Schaffner. 2006. Community-associated methicillin-resistant Staphylococcus aureus: the way to the wound is through the nose. J. Infect. Dis. 193:169-171.
11. Dall'Antonia, M., P. G. Coen, M. Wilks, A. Whiley, and M. Millar. 2005. Competition between methicillin-sensitive and methicillin-resistant Staphylococcus aureus in the anterior nares. J. Hosp. Infect. 61:62-67.
12. Davis, K. A., J. J. Stewart, H. K. Crouch, C. E. Florez, and D. R. Hospenthal. 2004. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin. Infect. Dis. 39:776-782.
13. Deresinski, S. 2005. Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic Odyssey. Clin. Infect. Dis. 40:562-573.
14. Doebbeling, B. N., D. R. Reagan, M. A. Pfaller, A. K. Houston, R. J. Hollis, and R. P. Wenzel. 1994. Long-term efficacy of intranasal mupirocin ointment: a prospective cohort study of Staphylococcus aureus carriage. Arch. Intern. Med. 154:1505-1508.
15. Ellis, M. W., D. R. Hospenthal, D. P. Dooley, P. G. Gray, and C. K. Murray. 2004. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin. Infect. Dis. 39: 971-979.
16. Finlay, J. E., L. A. Miller, and J. A. Poupard. 1997. Interpretive criteria for testing susceptibility of staphylococci to mupirocin. Antimicrob. Agents Chemother. 41:1137-1139.
17. Flayhart, D., J. F. Hindler, D. A. Bruckner, G. Hall, R. K. Shrestha, S. A. Vogel, S. S. Richter, W. Howard, R. Walther, and K. C. Carroll. 2005. Multicenter evaluation of BBL CHROMagar MRSA medium for direct detection of methicillin-resistant Staphylococcus aureus from surveillance cultures of the anterior nares. J. Clin. Microbiol. 43:5536-5540.
18. Fleiss, J. L., B. Levin, and M. C. Paik. 2003. Statistical methods for rates and proportions, 3rd ed. John Wiley and Sons, New York, NY.
19. Francis, J. S., M. C. Doherty, U. Lopatin, C. P. Johnston, G. Sinha, T. Ross, M. Cai, N. N. Hansel, T. Perl, J. R. Ticehurst, K. Carroll, D. L. Thomas, E. Nuermberger, and J. G. Bartlett. 2005. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin. Infect. Dis. 40:100-107.
20. Fridkin, S. K., J. C. Hageman, M. Morrison, L. T. Sanza, K. Como-Sabetti, J. A. Jernigan, K. Harriman, L. H. Harrison, R. Lynfield, and M. M. Farley. 2005. Methicillin-resistant Staphylococcus aureus in three communities. N. Engl. J. Med. 352:1436-1444.
21. Fuller, A. T., G. Mellows, M. Woolford, G. T. Banks, K. D. Barrow, and E. B. Chain. 1971. Pseudomonic acid: an antibiotic produced by Pseudomonas fluorescens. Nature 234:416-417.
22. Gonzalez, B. E., G. Martinez-Aguilar, K. G. Hulten, W. A. Hammerman, J. Coss-Bu, A. Avalos-Mishaan, E. O. Mason, and S. L. Kaplan. 2005. Severe staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics 115:642-648.
23. Groom, A. V., D. H. Wolsey, T. S. Naimi, K. Smith, S. Johnson, D. Boxrud, K. A. Moore, and J. E. Cheek. 2001. Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA 286:1201-1205.
24. Hart, A. C., and C. A. Hopkins (ed.). 2001. ICD-9-CM: International Classification of Diseases, 9th revision, clinical modification, 6th ed. St. Anthony Publishing, Reston, VA.
25. Healy, C. M., K. G. Hulten, D. L. Palazzi, J. R. Campbell, and C. J. Baker. 2004. Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Clin. Infect. Dis. 39:1460-1466.
26. Kalmeijer, M. D., H. Coertjens, P. M. van Nieuwland-Bollen, D. Bogaers-Hofman, G. A. de Baere, A. Stuurman, A. van Belkum, and J. A. Kluytmans. 2002. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin. Infect. Dis. 35:353-358.
27. Kazakova, S. V., J. C. Hageman, M. Matava, A. Srinivasan, L. Phelan, B. Garfinkel, T. Boo, S. McAllister, J. Anderson, B. Jensen, D. Dodson, D. Lonsway, L. K. McDougal, M. Arduino, V. J. Fraser, G. Killgore, F. C. Tenover, S. Cody, and D. B. Jernigan. 2005. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N. Engl. J. Med. 352:468-475.
28. King, M. D., B. J. Humphrey, Y. F. Wang, E. V. Kourbatova, S. M. Ray, and H. M. Blumberg. 2006. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann. Intern. Med. 144:309-317.
29. Kluytmans, J., A. van Belkum, and H. Verbrugh. 1997. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin. Microbiol. Rev. 10:505-520.
30. Kresken, M., D. Hafner, F. Schmitz, and T. A. Wichelhaus. 2004. Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: results of the Antimicrobial Resistance Surveillance Study of Paul-Ehrlich-Society for Chemotherapy, 2001. Int. J. Antimicrob. Agents 23:577-581.
31. Kuehnert, M. J., D. Kruszon-Moran, H. A. Hill, G. McQuillan, S. K. McAllister, G. Fosheim, L. K. McDougal, J. Chaitram, B. Jensen, S. K. Fridkin, G. Killgore, and F. C. Tenover. 2006. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J. Infect. Dis. 193:172-179.
32. LaMar, J., R. Carr, C. Zinderman, and K. McDonald. 2003. Sentinel case of community-acquired methicillin-resistant Staphylococcus aureus onboard a naval ship. Mil. Med. 168:135-138.
33. Laupland, K. B., and J. M. Conly. 2003. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review. Clin. Infect. Dis. 37:933-938.
34. Lindenmayer, J. M., S. Schoenfeld, R. O'Grady, and J. K. Carney. 1998. Methicillin-resistant Staphylococcus aureus in a high school wrestling team and the surrounding community. Arch. Intern. Med. 158:895-899.
35. Martinez-Aguilar, G., A. Avalos-Mishaan, K. Hulten, W. Hammerman, E. O. Mason, and S. L. Kaplan. 2004. Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr. Infect. Dis. J. 23:701-706.
36. McDougal, L. K., C. D. Steward, G. E. Killgore, J. M. Chaitram, S. K. McAllister, and F. C. Tenover. 2003. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J. Clin. Microbiol. 41:5113-5120.
37. Miller, L. G., F. Perdreau-Remington, G. Rieg, M. Sheherbano, J. Perlroth, A. S. Bayer, A. W. Tang, T. O. Phung, and B. Spellberg. 2005. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N. Engl. J. Med. 352:1445-1453.
38. Miller, M. A., A. Dascal, J. Portnoy, and J. Mendelson. 1996. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect. Control. Hosp. Epidemiol. 17:811-813.
39. Moran, G. J., A. Krishnadasan, R. J. Gorwitz, G. E. Fosheim, L. K. McDougal, R. B. Carey, and D. A. Talan. 2006. Methicillin-resistant S. aureus infections among patients in the emergency department. N. Engl. J. Med. 355:666-674.
40. The Mupirocin Study Group. 1996. Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. J. Am. Soc. Nephrol. 7:2403-2408.
41. Nguyen, D. M., L. Mascola, and E. Bancroft. 2005. Recurring methicillin-resistant Staphylococcus aureus in a football team. Emerg. Infect. Dis. 11: 526-532.
42. Nouwen, J. L., A. Ott, M. F. Kluytmans-Vandenbergh, H. A. Boelens, A. Hofman, A. van Belkum, and H. A. Verbrugh. 2004. Predicting the Staphylococcus aureus nasal carrier state: derivation and validation of a "culture rule." Clin. Infect. Dis. 39:806-811.
43. Perl, T. M., J. J. Cullen, R. P. Wenzel, M. B. Zimmerman, M. A. Pfaller, D. Sheppard, J. Twombley, P. P. French, L. A. Herwaldt, and the Mupirocin and the Risk of Staphylococcus aureus Study Team. 2002. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections in patients. N. Engl. J. Med. 346:1871-1877.
44. Tacconelll, E., Y. Carmell, A. Aizer, G. Ferreira, M. G. Foreman, and E. M. C. D'Agata. 2003. Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin. Infect. Dis. 37:1629-1638.
45. Tenover, F. C., R. D. Abreit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
46. von Elff, C., K. Becker, K. Machka, H. Stammer, and G. Peters. 2001. Nasal carriage as a source of Staphylococcus aureus bacteremia. N. Engl. J. Med. 344:11-16.
47. Weber, J. T. 2005. Community-associated methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 41(Suppl.):S269-S272.
48. Wertheim, H. F., D. C. Melles, M. C. Vos, W. van Leeuwen, A. van Belkum, H. A. Verbrugh, and J. L. Nouwen. 2005. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect. Dis. 5:751-762.
49. Wertheim, H. F., J. Verveer, H. A. Boelens, A. van Belkum, H. A. Verbrugh, and M. C. Vos. 2005. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults. Antimicrob. Agents Chemother. 49:1465-1467.
50. Wertheim, H. F., M. C. Vos, A. Ott, A. van Belkum, A. Vos, J. A. Kluytmans, P. H. van Keulen, C. M. Vandenbroucke-Grauls, and H. A. Verbrugh. 2004. Risk and outcome of nosocomial Staphylococcus aureus in nasal carriers versus non-carriers. Lancet 364:703-705.
51. Wertheim, H. F., M. C. Vos, A. Ott, A. Voss, J. A. Kluytmans, C. M. Vandenbroucke-Grauls, M. H. Meester, P. H. van Keulen, and H. A. Verbrugh. 2004. Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients. Ann. Intern. Med. 140:419-425.
52. Williams, R. E. O. 1963. Healthy carriage of Staphylococcus aureus: its prevalence and importance. Bacteriol. Rev. 27:56-71.
53. Yu, V. L., A. Goetz, M. Wagener, P. B. Smith, J. D. Rihs, J. Hanchett, and J. J. Zuravleff. 1986. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. N. Engl. J. Med. 315:91-96.
54. Zinderman, C. E., B. Conner, M. A. Malakooti, J. E. LaMar, A. Armstrong, and B. K. Bohnker. 2004. Community-acquired methicillin-resistant Staphylococcus aureus among military recruits. Emerg. Infect. Dis. 10:941-944.